DeVito M J, Diliberto J J, Ross D G, Menache M G, Birnbaum L S
Experimental Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
Toxicol Appl Pharmacol. 1997 Dec;147(2):267-80. doi: 10.1006/taap.1997.8261.
The dose-response relationships for induction of liver, lung, and skin ethoxyresorufin-O-deethylase (EROD) activity and liver acetanilide-4-hydroxylase (ACOH) activity following subchronic exposure to either 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin, 2,3,7,8-tetrabromodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran (TCDF), 1,2,3,7,8-pentachlorodibenzofuran (1-PeCDF), 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF), or octachlorodibenzofuran (OCDF) were determined in female B6C3F1 mice in order to estimate the relative enzyme inducing potency of these chemicals in three different tissues. The relative potencies were calculated based on tissue concentrations as well as administered dose. A dose-dependent induction of EROD activity in liver, lung, and skin and of ACOH activity in liver was found for all seven chemicals. When based on administered dose, the relative potencies for specific congeners did not vary substantially among tissues. The relative potencies for TCDF and 1-PeCDF, congeners which have much shorter half-lives than TCDD, increased for all enzymes when estimated from tissue concentrations. The relative potency of OCDF, which is poorly absorbed, was greater when estimated from tissue concentrations than when estimated from administered dose. 4-PeCDF is highly sequestered in hepatic tissue and when the relative potency was estimated based on tissue concentration, its potency for skin enzyme induction increased. These data indicate that the relative potency of these chemicals is influenced not only by the relative binding affinity to the Ah receptor, but also by differences in pharmacokinetic properties of these chemicals. In addition, it may be useful to derive two sets of toxic equivalency factor values, one used for estimating intake equivalents and the other for estimating tissue equivalents.
为了评估2,3,7,8 - 四氯二苯并 - p - 二恶英(TCDD)、1,2,3,7,8 - 五氯二苯并 - p - 二恶英、2,3,7,8 - 四溴二苯并 - p - 二恶英、2,3,7,8 - 四氯二苯并呋喃(TCDF)、1,2,3,7,8 - 五氯二苯并呋喃(1 - PeCDF)、2,3,4,7,8 - 五氯二苯并呋喃(4 - PeCDF)或八氯二苯并呋喃(OCDF)亚慢性暴露后对雌性B6C3F1小鼠肝脏、肺和皮肤乙氧基异吩恶唑酮 - O - 脱乙基酶(EROD)活性及肝脏乙酰苯胺 - 4 - 羟化酶(ACOH)活性的剂量 - 反应关系,以估计这些化学物质在三种不同组织中的相对酶诱导能力。相对效力是根据组织浓度以及给药剂量计算得出的。所有七种化学物质均呈现出肝脏、肺和皮肤中EROD活性以及肝脏中ACOH活性的剂量依赖性诱导。基于给药剂量时,特定同系物的相对效力在各组织间变化不大。对于TCDF和1 - PeCDF这两种半衰期比TCDD短得多的同系物,从组织浓度估算时,所有酶的相对效力均有所增加。吸收较差的OCDF,从组织浓度估算时的相对效力比从给药剂量估算时更大。4 - PeCDF高度蓄积于肝脏组织中,基于组织浓度估算相对效力时,其对皮肤酶诱导的效力增加。这些数据表明,这些化学物质的相对效力不仅受与芳烃受体相对结合亲和力的影响,还受这些化学物质药代动力学特性差异的影响。此外,推导两组毒性当量因子值可能是有用的,一组用于估计摄入当量,另一组用于估计组织当量。